Effect of various 6-hydroxydopamine treatments during development on growth and ingestive behavior
- PMID: 4816
- DOI: 10.1016/0091-3057(75)90023-4
Effect of various 6-hydroxydopamine treatments during development on growth and ingestive behavior
Abstract
Destruction of catecholamine-containing fibers in brain at 5 days of age with intracisternal injection of 6-hydroxydopamine reduced body growth, intake of a sucrose solution, and acquisition of an active avoidance response. Further characterization of behavioral deficits indicated that treated animals also showed reduced ingestion of saline solution when injected with desoxycorticosterone and a decreased eating response to insulin. In addition, all of these deficits produced by catecholamine depletion with 6-hydroxydopamine were observed in rats in which brain dopamine was preferentially reduced but not in rats having preferential destruction of noradrenergic fibers, suggesting that dopamine depletion amounts for the observed alterations in developing animals. Although animals treated with 6-hydroxydopamine at 14 days showed reduced intake of a sucrose solution, they did not have reduced growth. Since early malnourishment reduced growth, it seems possible that the reduced growth observed after destruction of dopaminergeic fibers may be related to an acute reduction of food intake which is perpetuated by persistent deficits in ingestive behavior. Evidence implicating malnourishment in other deficits produced by 6-hydroxydopamine could not be obtained.
Similar articles
-
Recovery of feeding and drinking by rats after intraventricular 6-hydroxydopamine or lateral hypothalamic lesions.Science. 1973 Nov 16;182(4113):717-20. doi: 10.1126/science.182.4113.717. Science. 1973. PMID: 4752211
-
Alterations in consummatory behavior following intracisternal injection of 6-hydroxydopamine.Pharmacol Biochem Behav. 1973 May-Jun;1(3):319-28. doi: 10.1016/0091-3057(73)90124-x. Pharmacol Biochem Behav. 1973. PMID: 4775860 No abstract available.
-
Growth and behavioral changes in developing rats treated intracisternally with 6-hydroxydopamine: evidence for involvement of brain dopamine.J Pharmacol Exp Ther. 1973 Jun;185(3):609-19. J Pharmacol Exp Ther. 1973. PMID: 4145870 No abstract available.
-
Developmental characteristics of brain catecholamines and tyrosine hydroxylase in the rat: effects of 6-hydroxydopamine.Br J Pharmacol. 1972 Feb;44(2):210-22. doi: 10.1111/j.1476-5381.1972.tb07257.x. Br J Pharmacol. 1972. PMID: 4148915 Free PMC article.
-
Relationship of dopamine neural systems to the behavioral alterations produced by 6-hydroxydopamine administration into brain.Adv Biochem Psychopharmacol. 1974;12(0):353-68. Adv Biochem Psychopharmacol. 1974. PMID: 4609223 Review. No abstract available.
Cited by
-
Dopaminergic but not noradrenergic mediation of hyperactivity and performance deficits in the developing rat pup.Psychopharmacology (Berl). 1984;82(1-2):73-7. doi: 10.1007/BF00426384. Psychopharmacology (Berl). 1984. PMID: 6420833
-
Dopamine-dependent synaptic plasticity in striatum during in vivo development.Proc Natl Acad Sci U S A. 2001 Jan 30;98(3):1255-60. doi: 10.1073/pnas.98.3.1255. Epub 2001 Jan 16. Proc Natl Acad Sci U S A. 2001. PMID: 11158626 Free PMC article.
-
Catecholamines: role in health and disease.Drugs. 1978 Nov;16(5):418-40. doi: 10.2165/00003495-197816050-00003. Drugs. 1978. PMID: 363400 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources